Lucintel Forecasts the Global Escherichia Coli Strain Market is expected to grow with a CAGR of 6.4% from 2024 to 2030
Lucintel Forecasts the Global Escherichia Coli Strain Market is expected to grow with a CAGR of 6.4% from 2024 to 2030
Blog Article
According to a market report by Lucintel, the future of the global escherichia coli strain market looks promising with opportunities in the academic and research institution, biotechnology and pharmaceutical company, clinical laboratory, and hospital and healthcare institution markets. The global escherichia coli strain market is expected to grow with a CAGR of 6.4% from 2024 to 2030. The major drivers for this market are increasing prevalence of escherichia coli infections and growing demand for personalized medicine and targeted therapies.
A more than 150-page report to understand trends, opportunity and forecast in escherichia coli strain market to 2030 by technology (spatial transcriptomics, spatial genomics sequencing, single-cell spatial analysis, and imaging-based spatial analysis), spatial data analysis tools (spatial data visualization, data integration and analysis software, and image analysis software), application (cancer research, neuroscience, developmental biology, immunology, infectious diseases, drug discovery, personalized medicine, and others), end use (academic and research institutions, biotechnology and pharmaceutical companies, clinical laboratories, hospitals and healthcare institutions, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the application category, neuroscience is expected to witness the highest growth over the forecast period due to increasing need in neurology for the escherichia coli strain.
Within the end use category, academic and research institution is expected to witness the highest growth.
Download sample by clicking on escherichia coli strain market
In terms of regions, APAC will remain the largest region over the forecast period due to growing awareness of e. coli infections and rising healthcare expenditure.
Thermo Fisher Scientific, Merck, Novozymes, QIAGEN, Promega, Agilent Technologies, New England Biolabs, Takara Bio, Bio-Rad Laboratories, GenScript Biotech are the major suppliers in the escherichia coli strain market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.comTo get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Protein Crystallization Market
copyright Drug Market
Skin Booster Market
Bismuth Market
Dolomite Powder Market